Investor Class Certified On Claims Pfizer Masked Drug Risks

Law360, New York (March 30, 2012, 4:52 PM EDT) -- A New York federal judge on Thursday certified a class of Pfizer Inc. investors accusing the pharmaceutical giant of securities fraud for allegedly concealing studies showing the heart attack risks linked to arthritis drugs Celebrex and Bextra.

U.S. District Judge Laura Taylor Swain said the plaintiffs, a class of investors who had bought Pfizer stock between October 2000 and October 2005, had adequately shown that there were questions of law and fact common to the class and that the class representative’s claims are typical of those...
To view the full article, register now.